October 26, 2021
12:15 - 13:00
Digital (MS Teams) or Atrium 3
Required - Please register here
Open to sitem-community & public Attendance free of charge
Cell therapies: Disruptive treatments require disruptive business models
Dr. Luc Henry, CEO and co-founder, Limula
Dr. Henry will discuss the challenges associated with the production of highly personalized cancer treatments, such as CART cell therapies. He will introduce Limula, a startup company he founded in order to provide the technological means necessary to make these ‘living drugs’ broadly accessible. He will then describe how this project, and cell therapy in general, require to radically rethink treatment supply chain and business models.